InvestorsHub Logo
Followers 76
Posts 5840
Boards Moderated 0
Alias Born 03/07/2017

Re: Chasing post# 7701

Sunday, 08/16/2020 1:28:32 PM

Sunday, August 16, 2020 1:28:32 PM

Post# of 44690
Say what? You mean the FDA is wrong?

Aviptadil is a formulation of Vasoactive Intestinal Polypeptide (VIP), which is present in high concentrations in the lungs and known to block various inflammatory cytokines. NeuroRx and Relief partnered to develop the drug in Covid-19 indication.

The drug candidate secured fast track designation from the US Food and Drug Administration (FDA) to treat respiratory distress associated with Covid-19.